CSL tied up the Vifor acquisition today.
There's been some speculation here that the appointment of Dr Elliot to the PIQ board could indicate that PIQ is on CSL's radar as a potentially complementary business.
Will be interesting to see what the stated strategy will be going forward.
Ann: Clinical Utility Study demonstrates PromarkerD test benefits, page-7
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
39.0¢ |
Change
-0.005(1.27%) |
Mkt cap ! $63.83M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 39.5¢ | 37.5¢ | $70.18K | 183.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 76292 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 39.0¢ | 24754 | 2 |
View Market Depth
| Last trade - 16.10pm 28/07/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |